A study by Xin et al. reported a decrease in ANXA6 gene expression in more malignant disease stages compared to benign prostate hyperplasia following a meta-analysis of four gene profiling studies [36]. This evidence concerns the gene ANXA6 and benign prostatic hyperplasia.